Thyroid hormone receptor isoform expression in livers of critically ill patients.
暂无分享,去创建一个
G. Van den Berghe | E. Fliers | W. Wiersinga | T. Visser | R. Peeters | D. Thijssen-Timmer | P. Wouters | F. Weekers | O. Bakker
[1] W. Wiersinga,et al. Contributions of cytokines to nonthyroidal illness , 2006 .
[2] G. Van den Berghe,et al. Tissue thyroid hormone levels in critical illness. , 2005, The Journal of clinical endocrinology and metabolism.
[3] G. Van den Berghe,et al. Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. , 2005, The Journal of clinical endocrinology and metabolism.
[4] G. Van den Berghe,et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. , 2004, Endocrinology.
[5] W. Wiersinga,et al. Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNA. , 2003, The Journal of endocrinology.
[6] G. Van den Berghe,et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.
[7] K. Feingold,et al. Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. , 2003, American journal of physiology. Endocrinology and metabolism.
[8] G. Berghe. Dynamic neuroendocrine responses to critical illness , 2002, Frontiers in Neuroendocrinology.
[9] Stefan Stamm,et al. Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.
[10] A. Kornblihtt,et al. Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.
[11] P. Larsen,et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.
[12] E. Ferrari,et al. Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. , 2002, Metabolism: clinical and experimental.
[13] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[14] T. Visser,et al. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. , 2001, Endocrine reviews.
[15] C. Wilson,et al. A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA. , 2001, RNA.
[16] B. Amir-Ahmady,et al. Regulation of the Processing of Glucose-6-phosphate Dehydrogenase mRNA by Nutritional Status* , 2001, The Journal of Biological Chemistry.
[17] Distinct Tissue-Specific Roles for Thyroid Hormone Receptors β and α1 in Regulation of Type 1 Deiodinase Expression , 2001 .
[18] A. Krainer,et al. Selection of Alternative 5′ Splice Sites: Role of U1 snRNP and Models for the Antagonistic Effects of SF2/ASF and hnRNP A1 , 2000, Molecular and Cellular Biology.
[19] G. Van den Berghe,et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.
[20] J. Manley,et al. Phosphorylation–dephosphorylation differentially affects activities of splicing factor ASF/SF2 , 1998, The EMBO journal.
[21] W. Wiersinga,et al. Expression of the alpha 1, alpha 2, and beta 1 T3-receptor mRNAs in the fasted rat measured using competitive PCR. , 1998, Biochemical and biophysical research communications.
[22] E. Fliers,et al. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.
[23] K. Yasuda,et al. Insulin regulated PKC isoform mRNA in rat adipocytes. , 1996, Diabetes research and clinical practice.
[24] W. Schaufeli,et al. Simplified Therapeutic Intervention Scoring System: the TISS-28 items--results from a multicenter study. , 1996 .
[25] A. Kosaki,et al. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. , 1993, The Journal of biological chemistry.
[26] J. Franklyn,et al. THYROID HORMONE RECEPTOR EXPRESSION IN THE "SICK EUTHYROID" SYNDROME , 1989, The Lancet.
[27] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[28] D. Cullen,et al. Therapeutic Intervention Scoring System: Update 1983 , 1983, Critical care medicine.
[29] T. Visser,et al. Radioimmunoassay of reverse tri-iodothyronine. , 1977, The Journal of endocrinology.
[30] D. Cullen,et al. Therapeutic intervention scoring system: a method for quantitative comparison of patient care. , 1974 .